Diroximel fumarate

Status:: Red
Decision Date:: November 2021

Comments

RED:

NICE TA794: Diroximel fumarate for treating relapsing–remitting multiple sclerosis. (NHSE commissioned). (Decision date - July 2022)

Red Drug Classifications

8. NHS England commissioned – to be used in line with NHSE commissioning intentions